Best Practices for the Development, Scale-up, and Post-approval Change Control of IR and MR Dosage Forms in the Current Quality-by-Design Paradigm

Journal Title: AAPS PharmSciTech - Year 2014, Vol 15, Issue 3

Abstract

In this whitepaper, the Manufacturing Technical Committee of the Product Quality Research Institute provides information on the common, best practices in use today in the development of high-quality chemistry, manufacturing and controls documentation. Important topics reviewed include International Conference on Harmonization, in vitro–in vivo correlation considerations, quality-by-design approaches, process analytical technologies and current scale-up, and process control and validation practices. It is the hope and intent that this whitepaper will engender expanded dialog on this important subject by the pharmaceutical industry and its regulatory bodies.

Authors and Affiliations

Glenn A. Van Buskirk, Satish Asotra, Christopher Balducci, Prabir Basu, Gerald DiDonato, Angelica Dorantes, W. Mark Eickhoff, Tapash Ghosh, Mario A. González, Theresa Henry, Matthew Howard, Jason Kamm, Steven Laurenz, Ryan MacKenzie, Richard Mannion, Patrick K. Noonan, Terrance Ocheltree, Umesh Pai, Richard P. Poska, Michael L. Putnam, Ramani R. Raghavan, Colleen Ruegger, Eric Sánchez, Vinod P. Shah, Zezhi Jesse Shao, Russell Somma, Vijay Tammara, Avinash G. Thombre, Bruce Thompson, Robert J. Timko, Satyam Upadrashta, Sivakumar Vaithiyalingam

Keywords

Related Articles

Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study

For the first-aid treatment of anaphylaxis, epinephrine (Epi) 0.3 mg intramuscular (IM) injection in the thigh is the drug of choice. Epi auto-injectors are widely recommended for anaphylaxis treatment in communi...

In Vitro and In Vivo Performance of Dry Powder Inhalation Formulations: Comparison of Particles Prepared by Thin Film Freezing and Micronization

Recently, inhaled immunosuppressive agents have attracted increasing attention for maintenance therapy following lung transplantation. The rationale for this delivery approach includes a more targeted and localized deliv...

Biodegradable Injectable In Situ Implants and Microparticles for Sustained Release of Montelukast: In Vitro Release, Pharmacokinetics, and Stability

The objective of this study was to investigate the sustained release of a hydrophilic drug, montelukast (MK), from two biodegradable polymeric drug delivery systems, in situ implant (ISI) and in situ microparticles (ISM)...

Novel Pentablock Copolymer-Based Nanoparticulate Systems for Sustained Protein Delivery

The design, synthesis, and application of novel biodegradable and biocompatible pentablock (PB) copolymers, i.e., polyglycolic acid-polycaprolactone-polyethylene glycol-polycaprolactone-polyglycolic acid (PGA-PCL-PEG-PCL...

Download PDF file
  • EP ID EP682423
  • DOI  10.1208/s12249-014-0087-x
  • Views 97
  • Downloads 0

How To Cite

Glenn A. Van Buskirk, Satish Asotra, Christopher Balducci, Prabir Basu, Gerald DiDonato, Angelica Dorantes, W. Mark Eickhoff, Tapash Ghosh, Mario A. González, Theresa Henry, Matthew Howard, Jason Kamm, Steven Laurenz, Ryan MacKenzie, Richard Mannion, Patrick K. Noonan, Terrance Ocheltree, Umesh Pai, Richard P. Poska, Michael L. Putnam, Ramani R. Raghavan, Colleen Ruegger, Eric Sánchez, Vinod P. Shah, Zezhi Jesse Shao, Russell Somma, Vijay Tammara, Avinash G. Thombre, Bruce Thompson, Robert J. Timko, Satyam Upadrashta, Sivakumar Vaithiyalingam (2014). Best Practices for the Development, Scale-up, and Post-approval Change Control of IR and MR Dosage Forms in the Current Quality-by-Design Paradigm. AAPS PharmSciTech, 15(3), -. https://europub.co.uk/articles/-A-682423